Skip to main content
. 2010 Apr;82(4):529–534. doi: 10.4269/ajtmh.2010.09-0334

Figure 2.

Figure 2.

Summary of final treatment outcome based on msp2, msp1, and TA81 genotyping. Follow-up bleed (FUB). * Genotyping of the microsatellite TA81 was only performed for infections occurring within 28 days after Coartem treatment. Samples collected between Day 28 and Day 42 after treatment was genotyped only for msp2 and msp1.